Cofoe Medical Technology (HKG:1187, SHE:301087) agreed to acquire a 60% equity interest in Hefei Kangjuren Medical Device Technology from three sellers for 99.5 million yuan.
The target engages mainly in the research and development, production, sales, and servicing of medical devices, principally oxygen concentrators and nebulizers, a Thursday bourse filing showed.
The sellers comprise the company's founding shareholders Guo Bensheng and Guo Benli, alongside Anhui Yangjingling Enterprise Management Consulting.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments